Advertisement


Advertisement

Thread Rating:
  • 4 Vote(s) - 3.25 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Scientists Rediscover Gene Target for Cancer Therapy
Advertisement
#1
While microRNAs are natural negative regulators of protein coding genes, miR-122 is characteristically suppressed in hepatocelluar carcinomas, and conversely its therapeutic re-expression was found to reverse the tumorigenic properties of the cancer cells in terms of growth, replication potential, invasion, and tumor formation (Bai et al., J Biol Chem, 2009). Scientists working in Italy and the USA, using miRNA libraries as probes in high throughput microarray assays to screen for sequences that are dysregulated in human cancers, independently implicated miR-122 in the pathogenesis of liver cancer and further demonstrated that the tumor suppressive action of this particular mRNA is manifested through the inhibition of the Cyclin G1 gene (Gramantieri et al., Cancer Res, 2009).

The finding that the natural suppression of the Cyclin G1 gene is lost in cancer cells is not at all surprising to scientists at Epeius Biotechnologies, who first identified the human Cyclin G1 gene as a proto-oncogene in 1994, demonstrated its therapeutic potential in a comprehensive series of landmark studies (1995-2005), and designed the sophisticated dominant-negative knockout construct embodied in the powerful anti-cancer agent Rexin-G (see Gordon and Hall, Intl. J. Oncology, 2009).

According to Dr. Frederick L. Hall, President and CEO of Epeius Biotech, It is gratifying to find that functional genomics and high-throughput screening have finally served to direct basic research away from simplistic antibodies and superficial blockades of receptor-mediated pathways to the crux of the matter and the final common pathways of cell cycle control. Moreover, it is always reassuring when a basic mechanistic understanding of the logic and executive enzymology of a biochemical pathway serves to trump the rolling of dice.

The finding that miR-122 targets Cyclin G1 gene expression confirms that Rexin-G may indeed be restoring a natural tumor suppressor function that is lost in the development and progression of many types of cancer; while the pathotropic (or disease-seeking) properties of Rexin-G function to deliver this agreeably rational and strategic anti-cancer agent precisely where it is needed most.

Reply
Thanks given by:
Advertisement
#2
Bug 
Hope less cancer...................:hot:
Reply
Thanks given by:
Advertisement




Possibly Related Threads...
Thread Author Replies Views Last Post
  Help: Tea therapy: To lose weight, don't add milk to your cuppa nairrk 0 915 03-28-2011, 09:56 AM
Last Post: nairrk
Information Help: Petrol stations near homes carry cancer risk nairrk 3 903 02-08-2011, 08:44 AM
Last Post: greatsadiq
  Help: Breast Cancer Patients With Diabetes Need Better Care Mr.AB 0 669 01-20-2011, 02:48 PM
Last Post: Mr.AB
Lightbulb Help: Scientists unlock secret of enternal youth.!! nairrk 0 577 11-30-2010, 08:20 AM
Last Post: nairrk
  Scientists find most massive star ever discovered Mr.Bhat 0 881 07-21-2010, 05:30 PM
Last Post: Mr.Bhat
  A treatment is discovered for the deadly blood cancer Mr.Bhat 0 695 07-18-2010, 08:27 AM
Last Post: Mr.Bhat
  American Scientists Create HIV Resistant Cells Mr.Bhat 2 866 07-05-2010, 08:52 PM
Last Post: Mr.Bhat
Heart Zydus Cadila Launches Anti-Cancer Drug “Nudoxa” Mr.Bhat 0 1,468 06-30-2010, 11:52 AM
Last Post: Mr.Bhat
  Yearly Horoscope of 2010 for the Zodiac Sign Cancer Mr.Bhat 0 850 01-04-2010, 09:00 AM
Last Post: Mr.Bhat
  Cracking the cancer code Mr.Bhat 0 868 12-17-2009, 11:53 AM
Last Post: Mr.Bhat

Forum Jump:


Users browsing this thread: 1 Guest(s)
Advertisement